Zidovudine

Basic Information

CAS ID: 30516-87-1
Molecular Formula: C10H13N5O4
Molecular Weight: 267.3 g/mol
Monoisotopic Mass: 267.0968 g/mol
Class: Small Molecule
Natural Product: No
Other Names: RETROVIR | ZIDOVUDINE | BWA509U | BW A509U | COMPOUND S | BW-A-509U | Azidothymidine | AZT
Analysis: Drug repositioning mechanism analysis

N N N+ N- OH O O NH O

Compound Structure and Identifier

InChI: InChI=1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)/t6-,7+,8+/m0/s1 See All
InChI Key: HBOMLICNUCNMMY-XLPZGREQSA-N
Smiles: CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O See All
Molfile: Download

Related Target

Related Fibrosis Property

Trial Record 1

ClinicalTrial ID NCT00490620 Disease Liver fibrosis
Phase Phase 2,Phase 3 Status Completed
First Received June 25, 2007 Last Verified November 1, 2007
Sponsor University of Alberta

Trial Record 2

ClinicalTrial ID NCT00000990 Disease Liver fibrosis
Phase Phase 2 Status Completed
First Received August 31, 2001 Last Verified March 16, 2012
Sponsor National Institute of Allergy and Infectious Diseases (NIAID)

Trial Record 3

ClinicalTrial ID NCT01908660 Disease Liver fibrosis
Phase Status Completed
First Received July 26, 2013 Last Verified November 11, 2015
Sponsor Valme University Hospital

Related Link

PubChem: 35370
ChEMBL: CHEMBL129